787 Pharmacodynamic study of serum EGFR and HER2 in patients with non-small cell lung cancer treated with ZD 1839

V. Gregorc, G.L. Ceresoli, F. Cappuzzo, I. Floriani, V. Ludovini, K. Bencardino, A. Spreafico, L. Pistola, M. Tonato, E. Villa
  • European Journal of Cancer Supplements, September 2003, Elsevier
  • DOI: 10.1016/s1359-6349(03)90812-3

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Federico Cappuzzo